Matrix Clinical Solution At-Home COVID-19 Test — Class II medical device recall Z-0947-2022
Ongoing recall by Matrix Medical Network, reported 2022-04-27, distributed in AL, AZ, CA, CO, CT, DC, DE, FL…. Due to COVID-19 Test not being authorized for home sample collection.
| Recall number | Z-0947-2022 |
|---|---|
| Product type | Medical device |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Matrix Medical Network, Scottsdale, AZ, United States |
| Recall initiated | 2022-01-24 |
| Classified | 2022-04-15 |
| Reported by FDA | 2022-04-27 |
| Distributed | AL, AZ, CA, CO, CT, DC, DE, FL, GA, LA, MA, MD, MI, MN, NH, NJ, NY, OH, OK, PA, TN, TX, UT, VA, WV |
| Quantity | 3,226 kits |
Product
Matrix Clinical Solution At-Home COVID-19 Test
Reason for recall
Due to COVID-19 Test not being authorized for home sample collection.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/Z-0947-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.